Jonathan Violin, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 59,091 shares at $19.55 ($1.1M) on 2022-02-01, disclosed to the SEC on 2022-02-03.
Open-market sale of $1.1M VRDN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.55 | 16,751 | $327K | 29.0% |
| 2 | $19.55 | 16,751 | $327K | 29.0% |
| 3 | $18.47 | 12,340 | $228K | 20.2% |
| 4 | $18.47 | 12,340 | $228K | 20.2% |
| 5 | $19.16 | 909 | $17K | 1.5% |
| Total | $19.09 avg | 59,091 |
| $1.1M |
| 100% |
| Filing → |
| VRDN | SELL | 2022-05-04 | $391K | — | Filing → |
| VRDN | SELL | 2022-04-05 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-03-03 | $1.1M | — | Filing → |